一个多中心的观察研究
Olivieri Silvia1, Sara Mazzanti2, Gabriele Gelo Signorino2,3
1Infectious Diseases, Via Murri, 15, 63023 Fermo, Italy.
Antibiotics (Basel, Switzerland)
|August 28, 2025
概括
在重症患者中,Ceftazidime- avibactam (CAZ- AVI) 显示中等效果,阳性结局率为58%. 然而,抗药性迅速发展需要谨慎的抗菌管理,以优化CAZ-AVI在重症监护室的使用.
科学领域:
- 传染性疾病
- 危急护理医学
- 药理学
背景情况:
- 塞法胺- 艾维巴克坦 (CAZ- AVI) 是一种重要的静脉注射细菌感染的抗生素.
- 关于CAZ- AVI在重症患者群体中的有效性和安全性的数据有限.
- 这项研究解决了在重症监护室 (ICU) 设置中更多证据的需求.
研究的目的:
- 在接受CAZ- AVI治疗的危急病患者中评估30天的临床结果.
- 确定与30天临床失败相关的风险因素,包括死亡和复发.
- 在ICU队列中评估CAZ-AVI的疗效和安全性.
主要方法:
- 在四个重症监护室进行了一项多中心,回顾性,观察性队列研究.
- 包括161名接受CAZ- AVI治疗至少72小时的成年重病患者.
- 患者因确诊或怀疑的格拉姆阴性细菌感染而接受治疗.
主要成果:
- 在58%的患者中,CAZ- AVI取得了积极的临床结果,总死亡率为24%.
- 25% 的患者出现复发或持续感染,26% 的患者发展成抗药性.
- 免疫抑制患者,特别是肝移植患者的治疗失败率更高.
结论:
- 在ICU患者中的CAZ- AVI死亡率与其他研究相似.
- 迅速出现的CAZ-AVI耐药性突显了对抗菌药物管理的需要.
- 优化药物动力学/ 药物动力学 (PK/ PD) 特性对于在重症患者中有效使用CAZ- AVI至关重要.
更多相关视频
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
7.1K
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
1.2K
相关概念视频
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
01:17Urinary Tract Infection IV: Nursing Management
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...